Oruka Therapeutics, Inc. · NASDAQ:ORKA
Agarwal Arjun sold 10,000 Oruka Therapeutics, Inc. shares (Form 4)
Traded Nov 12, 2026 · Filed Nov 13, 2026
On Nov 12, 2026, Agarwal Arjun (Senior Vice President, Finance) sold 10,000 Oruka Therapeutics, Inc. shares at an average US$104.97 for US$1.05M under a trading plan, leaving 14,219 shares. Filed Nov 13, 2026 (Form 4).
- Sold
- 10,000 shares
- Price
- US$104.97 average (US$101.98 to US$107.00)
- Value
- US$1.05M
- Holding after
- 14,219 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Senior Vice President, Finance
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | Common Stock | Option exercise | 8,542 | US$12.50 | 22,761 | Direct |
| Nov 12, 2026 | Common Stock | Option exercise | 1,458 | US$34.39 | 24,219 | Direct |
| Nov 12, 2026 | Common Stock | Sale | 500 | US$101.98 | 23,719 | Direct |
| Nov 12, 2026 | Common Stock | Sale | 801 | US$103.16 | 22,918 | Direct |
| Nov 12, 2026 | Common Stock | Sale | 799 | US$104.25 | 22,119 | Direct |
| Nov 12, 2026 | Common Stock | Sale | 6,842 | US$105.28 | 15,277 | Direct |
| Nov 12, 2026 | Common Stock | Sale | 958 | US$106.18 | 14,319 | Direct |
| Nov 12, 2026 | Common Stock | Sale | 100 | US$107.00 | 14,219 | Direct |
Source
Download original · View original at SEC
Related
- Oruka Therapeutics, Inc.
- Agarwal Arjun
- Oruka Therapeutics, Inc. shareholders
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Agarwal Arjun · Sep 21, 2026
- Form 4 · Agarwal Arjun · Sep 15, 2026
- Form 4 · Agarwal Arjun · Aug 14, 2026
- Form 4 · Agarwal Arjun · Jul 13, 2026
- Form 4 · Quinlan Paul T · Nov 20, 2026
- Form 4 · Goncalves Joana · Nov 16, 2026
- Schedule 13G/A · Rtw Investments, LP · Nov 16, 2026
- Schedule 13G · T. Rowe Price Investment Management, Inc. · Nov 16, 2026
- Form 4 · Ball Kristine M · Nov 13, 2026